SCHEMBL30832233

SCHEMBL30832233

CN1CCCOc2nccc3ncnc1c23

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTK2 Q05397 1/20 0.35
HRH4 Q9H3N8 1/20 0.35
RET P07949 1/20 0.35
PRKCQ Q04759 3/20 0.34
LRRK2 Q5S007 2/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
RAB9A P51151 1/20 0.32
GFER P55789 1/20 0.32
LMNA P02545 3/20 0.32
HTT P42858 3/20 0.32
PRKDC P78527 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
NCOA3 Q9Y6Q9 1/20 0.32
USP2 O75604 2/20 0.31
ALDH1A1 P00352 2/20 0.31
CYP1A2 P05177 2/20 0.31
CYP3A4 P08684 2/20 0.31
CYP2D6 P10635 2/20 0.31
HIF1A Q16665 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30832371 0.79 GRM5 (0.40) PTK2HRH4RETPRKCQMEN1
SCHEMBL30832314 0.73 LRRK2 (0.30) HRH4LRRK2
SCHEMBL30832276 0.71 RET (0.32) RET
SCHEMBL29999565 0.70 GRM5 (0.48) PTK2HRH4MEN1KMT2ALMNA
SCHEMBL31189011 0.68 MEN1 (0.54) MEN1KMT2ARAB9ALMNAHTT
SCHEMBL31491230 0.68 MEN1 (0.54) MEN1KMT2ARAB9ALMNAHTT
SCHEMBL30832288 0.67 RET (0.36) RETGRM5
SCHEMBL31490763 0.66 MEN1 (0.31) MEN1KMT2ARAB9ALMNAHTT
SCHEMBL31491223 0.65 JAK2 (0.33) MEN1KMT2ARAB9ALMNAHTT
SCHEMBL31490762 0.65 JAK2 (0.33) MEN1KMT2ARAB9ALMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4568974-A1 HETEROCYCLIC COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH BeiGene Switzerland GmbH (CH) 2025-06-18 EP disclosed
WO-2024032702-A1 HETEROCYCLIC COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH BEIGENE, LTD. (KY) 2024-02-15 WO disclosed